TRAVERE THERAPEUTICS INC (TVTX) Stock Balance Sheet
USA - NASDAQ:TVTX - US89422G1076 - Common Stock
32.34 USD
-0.96 (-2.88%)
32.34 USD
0 (0%)
| MRQ (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | 110.93M | 58.53M | 58.18M | 61.70M | 165.80M | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | 143.60M | 312.17M | 508.68M | 388.60M | 387.10M | |||
| Receivables | 82.98M | 27.12M | 21.18M | 16.60M | 16.20M | |||
| Inventories | 5.55M | 6.20M | 9.41M | 6.90M | 7.30M | |||
| Other Current Assets | 28.05M | 12.69M | 19.34M | 12.60M | 6.50M | |||
| Total Current Assets | 371.11M | 416.70M | 616.77M | 486.40M | 582.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 15.78M | 19.63M | 25.54M | 30.00M | 34.30M | |||
| Investments And Advances | null | null | null | null | null | |||
| Goodwill | 753.00K | 753.00K | 753.00K | 900.00K | 900.00K | |||
| Intangibles | 108.68M | 103.22M | 103.69M | 144.10M | 147.50M | |||
| Other Non-Current Assets | 42.25M | 53.82M | 42.16M | 11.10M | 11.10M | |||
| Total Non-Current Assets | 167.47M | 177.42M | 172.14M | 186.20M | 193.80M | |||
| TOTAL ASSETS | 538.58M | 594.13M | 788.91M | 672.60M | 776.60M | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | 0 | 68.68M | null | null | null | |||
| Accrued Expenses | 94.63M | 75.34M | 97.89M | 74.10M | 52.20M | |||
| Accounts Payable | 18.23M | 23.53M | 41.67M | 17.30M | 15.10M | |||
| Other Current Liabilities | 22.22M | 33.20M | 38.34M | 50.80M | 56.70M | |||
| Total Current Liabilities | 135.07M | 200.75M | 177.91M | 142.20M | 124.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 311.37M | 310.31M | 377.26M | 375.50M | 226.60M | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | 18.57M | 23.99M | 32.93M | 112.00M | 123.90M | |||
| Total Non-Current Liabilities | 329.94M | 334.30M | 410.19M | 487.50M | 350.40M | |||
| TOTAL LIABILITIES | 465.02M | 535.05M | 588.10M | 629.70M | 474.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.48B | -1.45B | -1.13B | -1.01B | -766.00M | |||
| Additional Paid In Capital | 1.55B | 1.51B | 1.33B | 1.06B | 1.07B | |||
| Minority Interest | null | null | null | null | null | |||
| Common Shares | 9.00K | 9.00K | 7.00K | 0 | 0 | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | -1.05M | -80.00K | -1.46M | -2.90M | -600.00K | |||
| Shares Outstanding | 89.46M | 87.45M | 75.37M | 64.30M | 62.50M | |||
| Tangible Book Value per Share | -0.401 | -0.5134 | 1.2786 | -1.5879 | 2.4592 | |||
| Total Shareholders' Equity | 73.56M | 59.08M | 200.81M | 42.90M | 302.10M | |||
| TOTAL LIABILITIES AND EQUITY | 538.58M | 594.13M | 788.91M | 672.60M | 776.60M | |||
| Statistics | ||||||||
| Debt/Equity | 4.23 | 5.25 | 1.88 | 8.75 | 0.75 | |||
| Current Ratio | 2.75 | 2.08 | 3.47 | 3.42 | 4.70 | |||
| Return On Assets (ROA) | -16.44% | -54.12% | -14.12% | -41.41% | -23.19% | |||
| Return On Equity (ROE) | -120.36% | -544.28% | -55.47% | -649.18% | -59.62% | |||
All data in USD , ROIC based on taxRate of 0.21